'On standalone basis
Quarter ended March 2025 compared with Quarter ended March 2024.
Net sales (including other operating income) of Abbott India has increased 11.54% to Rs 1,604.59 crore. Operating profit margin has jumped from 22.91% to 26.71%, leading to 30.05% rise in operating profit to Rs 428.54 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 10.49% to 10.84%. Purchase of finished goods cost fell from 48.47% to 45.71%. Employee cost decreased from 9.42% to 8.38%. Other expenses fell from 10.25% to 10.20%.
Other income fell 6.32% to Rs 76.02 crore. PBIDT rose 22.86% to Rs 504.56 crore. Provision for interest up 39.50% to Rs 3.92 crore. Loan funds rose to Rs 196.67 crore as of 31 March 2025 from Rs 83.23 crore as of 31 March 2024. Inventories rose to Rs 882.04 crore as of 31 March 2025 from Rs ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|